EMA — authorised 31 December 2009
- Application: EMEA/H/C/000838
- Marketing authorisation holder: Takeda Global Research Development Centre (Europe) Ltd.
- Local brand name: Ramelteon
- Status: withdrawn
EMA authorised Ramelteon Pill on 31 December 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 31 December 2009.
Takeda Global Research Development Centre (Europe) Ltd. holds the EU marketing authorisation.